Green Dot Corp., a Monrovia, Calif.-based seller of prepaid debit cards, raised $164.1 million in its IPO. The company priced 4.56 million shares at $36 per share, compared to plans to sell 4.17 million shares at between $32 and $35. It will trade on the NYSE under ticker symbol GDOT. Company shareholders include Sequoia Capital (31.9% pre-IPO stake) and Total Technology Partners (10.8%).
Euthymics Bioscience Inc., a Cambridge, Mass.-based developer of antidepressants, has raised $24 million in Series A fu! nding. The milestone-tranched deal was co-led by Novartis Venture Funds and Venture Investors, with H&Q Capital Management, LLC, GBS Venture Partners and the State of Wisconsin Investment Board also participating. Some proceeds were used to acquire DOV Pharmaceutical Inc.
NXP Semiconductors NV, a Dutch semiconductor company, has set its IPO terms to 34 million common shares being offered at between $18 and $21 per share. The company had originally filed to raise $1.15 billion, but now would only secure $714 million were it to price at the high end of its range (market cap would be $5.23 billion). It plans to trade on the Nasdaq under ticker symbol NXPI, with Credit Suisse, Morgan Stanley and Goldman Sachs serving as co-lead underwriters. NXP reports a $161 million net loss from 2009 on over $3.8 billion in sale! s. This compares to a $3.5 billion net loss in 2005 on $5.44 billion i n sales. It currently has $5.82 billion in debt on its balance sheet. The company was carved out of Phillips in 2006, via a $9.5 billion leveraged buyout. Shareholders include KKR (also an underwriter on the IPO, AlpInvest Partners, Apax Partners, Bain Capital, Silver Lake Partners and Phillips.
Validity Inc., a San Jose, Calif.-based provider of identity validation solutions, has raised $12.6 million in Series D funding. Panorama Capital led the round, and was joined by return backers TeleSoft Partners, Crosslink Capital, Qualcomm Ventures and VentureTech Alliance.
Integrated Diagnostics, a Seattle-based personalized diagnostics startup, has secured $10 million in new Series A funding. The investment was triggered by the achievement of certain clinical milestones. BioTechCube was joined by existing backers InterWest Partners, The Wellcome Trust and dievini Hopp BioTech Holding.
Interactions Corp., a Franklin, Mass.-based provider of customer care! communications for interactive systems, has raised $6.3 million in Series D funding. Backers include Cross Atlantic Capital Partners ($2.8m), North Hill Ventures, Sigma Partners and Updata Partners.
SeatGeek Inc., a New York-based secondary ticket market for sports and concert tickets, has raised $1 million in Series A funding. Founder Collective led the round, and was joined by NYC Seed. The company previously raised $500,000 from Stage One Capital, Trisiras Group, PKS Capital; and angel investors Arie Abecassis, Sunil Hirani, Thomas Lehrman, Allen Levinson and Mark Wachen. www.seatgeek.com
The Blackstone Group reportedly is in talks to buy a package of real estate loans owned by Morgan Stanley’s Japanese operations. The loans’ face value is around $1.14 billion.
LDC has agreed to buy Easynet, the B2B telecom unit of UK satellite broadcaster BSkyB (LSE: BSY). The deal is valued at £100 million.
TPG Capital has agreed to invest $300 million into Copano Energy (NYSE: CPNO), via a private placement of convertible preferred equity at $29.05 per unit. Copano’s shares closed yesterday at $27.54, down 50 cents.
Camelot Information Systems Inc. (NYSE: CIS), a Beijing-based provider of enterprise application services and financial industry IT services in China, had its shares close down 3.2% on its first day of trading. The company had raised $146.7 million in its IPO. Citigroup Venture Capital held a 29% pre-IPO stake.
Chesapeake Midstream Partners, a joint venture between Chesapeake Energy (NYSE: CHK) and Global Infrastructure Partners, set its IPO terms to 21.25 million units at between $19 and $21 per unit. It plans to trade on the NYSE under ticker symbol CHKM, with UBS, Citi and Morgan Stanley serving as co-lead underwriters.
NuPathe Inc., a Conshohocken, Penn.-based drug developer focused on the central nervous system, has set its IPO terms to five million common shares being offered at between $14 and $16 per share. It would have an initial market cap of approximately $225 million, were it to price at the high end of its range. The companyplans to trade on the Nasdaq under ticker symbol PATH, with Lazard Capital Markets and Leerink Swann serving as co-lead underwriters. It reports $11.3 million in 2009 revenue and a $15.6 million net loss. www.nupathe.com
Applied Voice & Speech Technologies Inc., a Foothill Ranch, Calif.-based, has agreed to buy certain assets ofVoice Mobility International Inc. No financial terms were disclosed. AVST backers include Ignition Partners and Dolphin Equity Partners.
The Blackstone Group and PAI Partners are talking to banks about a possible sale of joint portfolio company United Biscuits, which could generate more than £2 billion.
Oclaro Inc. (NASDAQ: OCLR) has agreed to acquire Mintera Corp., an Acton, Mass.-based provider of high bit-rate optical transport systems. The deal is valued at upwards of $32 million, including a $12 million up-front payment. Mintera had raised more than $73 million in VC funding since 2000, but VentureWire reports that a recent recap left just three primary shareholders: Court Square Ventures, RRE Ventures and Star Ventures.
Questel, a portfolio company of Syntegra Capital, has sold trademark solutions provider Edital to CT Corsearch, part of Wolters Kluwer Corporate Legal Services. No financial terms were disclosed.
Firms & Funds
Infrastructure Leasing & Financial Services Ltd. (IL&FS), an unlisted Indian lender, reportedly plans to raise around $400 million via the sale of an 8% ownership stake to new and existing investors.
Fotis Hasiotis has joined Lazard as co-head of European financial sponsors. He previously ran EMEA financial sponsors for BoA Merrill Lynch.